Pfizer, BioNTech Covid-19 Vaccine 90% Effective in Interim Analysis of Phase 3 Trial, Companies Say
^ Added at
{{ hourTwoDigit }}:{{ minuteTwoDigit }}
^ Added at
{{ hourTwoDigit }}:{{ minuteTwoDigit }}
Covid-19 vaccine from Pfizer and BioNTech is strongly effective, early data from large trial indicate
From statnews.com